NCT02473250View on ClinicalTrials.gov

Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Bipolar Disorder
Interventions
DRUG

Fluoxetine

Bipolar depressed patients will be treated with fluoxetine in combination with a mood stabilizer (valproate).

DRUG

Citalopram

Bipolar depressed patients will be treated with citalopram in combination with a mood stabilizer (valproate) if fluoxetine is not clinically warranted.

Trial Locations (1)

10032

New York State Psychiatric Institute/Columbia University Medical Center, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT02473250 - Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging | Biotech Hunter | Biotech Hunter